Patent classifications
C07C61/35
Unsaturated monomers and oligomers free of phenolics
Various embodiments disclosed relate to a resin having a structure of at least one of Formula I and Formula II: In Formula I or Formula II R.sup.1, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 can each be independently selected from the group consisting of hydrogen and substituted or unsubstituted (C.sub.1-C.sub.10)alkyl. R.sup.2 is (C.sub.1-C.sub.10) alkylene. L is a substituted or unsubstituted (C.sub.1-C.sub.10)alkylene or (C.sub.3-C.sub.10)cycloalkylene. In Formula I or Formula II, n or m is greater than or equal to 0, and wherein the resin has an average molecular weight of less than 10,000 g/mol. ##STR00001##
Unsaturated monomers and oligomers free of phenolics
Various embodiments disclosed relate to a resin having a structure of at least one of Formula I and Formula II: In Formula I or Formula II R.sup.1, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 can each be independently selected from the group consisting of hydrogen and substituted or unsubstituted (C.sub.1-C.sub.10)alkyl. R.sup.2 is (C.sub.1-C.sub.10) alkylene. L is a substituted or unsubstituted (C.sub.1-C.sub.10)alkylene or (C.sub.3-C.sub.10)cycloalkylene. In Formula I or Formula II, n or m is greater than or equal to 0, and wherein the resin has an average molecular weight of less than 10,000 g/mol. ##STR00001##
Cosmetic composition comprising vetiver root extract
A cosmetic composition is provided, which comprises a carrier and a Vetiver root extract, in particular an extract from exhausted Vetiver root. This composition provides a stimulation of sebum production, stimulation of sebum antimicrobial, lipids production, activation of adipocytes volume increase, skin hydration, skin tonicity booster, skin fatigue reduction, perilabial wrinkles reduction, skin replumping, and fragrance long-lastingness enhancement.
Cosmetic composition comprising vetiver root extract
A cosmetic composition is provided, which comprises a carrier and a Vetiver root extract, in particular an extract from exhausted Vetiver root. This composition provides a stimulation of sebum production, stimulation of sebum antimicrobial, lipids production, activation of adipocytes volume increase, skin hydration, skin tonicity booster, skin fatigue reduction, perilabial wrinkles reduction, skin replumping, and fragrance long-lastingness enhancement.
An Anticonvulsant Compound
The invention relates to pharmaceutical uses of compounds of formula (II). Particular aspects of the invention relate to the use of those compounds in treating, preventing or ameliorating a seizure-related disorder, bipolar disorder, mania, migraine, Alzheimer's disease, Parkinson's disease or stroke.
An Anticonvulsant Compound
The invention relates to pharmaceutical uses of compounds of formula (II). Particular aspects of the invention relate to the use of those compounds in treating, preventing or ameliorating a seizure-related disorder, bipolar disorder, mania, migraine, Alzheimer's disease, Parkinson's disease or stroke.
Cosmetic Composition Comprising Vetiver Root Extract
A cosmetic composition is provided, which comprises a carrier and a Vetiver root extract, in particular an extract from exhausted Vetiver root. This composition provides a stimulation of sebum production, stimulation of sebum antimicrobial, lipids production, activation of adipocytes volume increase, skin hydration, skin tonicity booster, skin fatigue reduction, perilabial wrinkles reduction, skin replumping, and fragrance long-lastingness enhancement.
Cosmetic Composition Comprising Vetiver Root Extract
A cosmetic composition is provided, which comprises a carrier and a Vetiver root extract, in particular an extract from exhausted Vetiver root. This composition provides a stimulation of sebum production, stimulation of sebum antimicrobial, lipids production, activation of adipocytes volume increase, skin hydration, skin tonicity booster, skin fatigue reduction, perilabial wrinkles reduction, skin replumping, and fragrance long-lastingness enhancement.
UNSATURATED MONOMERS AND OLIGOMERS FREE OF PHENOLICS
Various embodiments disclosed relate to a resin having a structure of at least one of Formula I and Formula II: In Formula I or Formula II R.sup.1, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 can each be independently selected from the group consisting of hydrogen and substituted or unsubstituted (C.sub.1-C.sub.10)alkyl. R.sup.2 is (C.sub.1-C.sub.10) alkylene. L is a substituted or unsubstituted (C.sub.1-C.sub.10)alkylene or (C.sub.3-C.sub.10)cycloalkylene. In Formula I or Formula II, n or m is greater than or equal to 0, and wherein the resin has an average molecular weight of less than 10,000 g/mol.
##STR00001##
UNSATURATED MONOMERS AND OLIGOMERS FREE OF PHENOLICS
Various embodiments disclosed relate to a resin having a structure of at least one of Formula I and Formula II: In Formula I or Formula II R.sup.1, R.sup.3, R.sup.4, R.sup.5, and R.sup.6 can each be independently selected from the group consisting of hydrogen and substituted or unsubstituted (C.sub.1-C.sub.10)alkyl. R.sup.2 is (C.sub.1-C.sub.10) alkylene. L is a substituted or unsubstituted (C.sub.1-C.sub.10)alkylene or (C.sub.3-C.sub.10)cycloalkylene. In Formula I or Formula II, n or m is greater than or equal to 0, and wherein the resin has an average molecular weight of less than 10,000 g/mol.
##STR00001##